These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26289674)

  • 1. Functionalised particles using dry powder coating in pharmaceutical drug delivery: promises and challenges.
    Dahmash EZ; Mohammed AR
    Expert Opin Drug Deliv; 2015; 12(12):1867-79. PubMed ID: 26289674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation and surface-profiling techniques for composite particles produced by dry powder coating in pharmaceutical drug delivery.
    Dahmash EZ; Mohammed AR
    Drug Discov Today; 2016 Apr; 21(4):550-61. PubMed ID: 26689131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.
    Alyami H; Dahmash E; Bowen J; Mohammed AR
    PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Particle Engineering Via Mechanical Dry Coating in the Design of Pharmaceutical Solid Dosage Forms.
    Qu L; Morton DA; Zhou QT
    Curr Pharm Des; 2015; 21(40):5802-14. PubMed ID: 26446461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanical methods for dry particle coating processes and their applications in drug delivery and development.
    Gera M; Saharan VA; Kataria M; Kukkar V
    Recent Pat Drug Deliv Formul; 2010 Jan; 4(1):58-81. PubMed ID: 19939220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of sustained release fine particles using two-step mechanical powder processing: particle shape modification of drug crystals and dry particle coating with polymer nanoparticle agglomerate.
    Kondo K; Ito N; Niwa T; Danjo K
    Int J Pharm; 2013 Sep; 453(2):523-32. PubMed ID: 23796831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dry coating, a novel coating technology for solid pharmaceutical dosage forms.
    Luo Y; Zhu J; Ma Y; Zhang H
    Int J Pharm; 2008 Jun; 358(1-2):16-22. PubMed ID: 18467045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of taste-masked swellable drug particles using dry-coating technology with mechanical curing.
    Saeki I; Kondo K; Furukoshi Y; Watanabe Y; Niwa T
    Eur J Pharm Biopharm; 2021 Mar; 160():9-22. PubMed ID: 33472100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of flow and bulk density of pharmaceutical powders using surface modification.
    Jallo LJ; Ghoroi C; Gurumurthy L; Patel U; Davé RN
    Int J Pharm; 2012 Feb; 423(2):213-25. PubMed ID: 22197769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on pharmaceutical film coating for drug delivery.
    Felton LA; Porter SC
    Expert Opin Drug Deliv; 2013 Apr; 10(4):421-35. PubMed ID: 23339342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders.
    Zhou QT; Armstrong B; Larson I; Stewart PJ; Morton DA
    Eur J Pharm Sci; 2010 Aug; 40(5):412-21. PubMed ID: 20433919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the potential for direct compaction of a fine ibuprofen powder dry-coated with magnesium stearate.
    Qu L; Zhou QT; Gengenbach T; Denman JA; Stewart PJ; Hapgood KP; Gamlen M; Morton DA
    Drug Dev Ind Pharm; 2015 May; 41(5):825-37. PubMed ID: 24738790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrostatic powder coating: Principles and pharmaceutical applications.
    Prasad LK; McGinity JW; Williams RO
    Int J Pharm; 2016 May; 505(1-2):289-302. PubMed ID: 27085644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the physical properties of dry surface-modified ibuprofen using a powder rheometer (FT4) and analysis of the influence of pharmaceutical additives on improvement of the powder flowability.
    Ono T; Yonemochi E
    Int J Pharm; 2020 Apr; 579():119165. PubMed ID: 32081804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells.
    Aquino RP; Prota L; Auriemma G; Santoro A; Mencherini T; Colombo G; Russo P
    Int J Pharm; 2012 Apr; 426(1-2):100-107. PubMed ID: 22301426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and prediction of powder flowability in pharmaceutical tableting.
    Hildebrandt C; Gopireddy SR; Fritsch AK; Profitlich T; Scherließ R; Urbanetz NA
    Pharm Dev Technol; 2019 Jan; 24(1):35-47. PubMed ID: 29227171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A New Role of Fine Excipient Materials in Carrier-Based Dry Powder Inhalation Mixtures: Effect on Deagglomeration of Drug Particles During Mixing Revealed.
    Shalash AO; Elsayed MMA
    AAPS PharmSciTech; 2017 Nov; 18(8):2862-2870. PubMed ID: 28421352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved blend and tablet properties of fine pharmaceutical powders via dry particle coating.
    Huang Z; Scicolone JV; Han X; Davé RN
    Int J Pharm; 2015 Jan; 478(2):447-55. PubMed ID: 25475016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low powder mass filling of dry powder inhalation formulations.
    Eskandar F; Lejeune M; Edge S
    Drug Dev Ind Pharm; 2011 Jan; 37(1):24-32. PubMed ID: 20738180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.
    Jetzer MW; Schneider M; Morrical BD; Imanidis G
    J Pharm Sci; 2018 Apr; 107(4):984-998. PubMed ID: 29247741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.